share_log
Reuters ·  Mar 17 20:05

Mar 17 (Reuters) - Sana Biotechnology Q4 Net Income USD -49.069 Million.

  • Q4 EPS USD -0.21
  • Q4 Operating Expenses USD 50.866 Million
  • Q4 Adjusted Net Income USD -54.785 Million Vs. IBES Estimate USD -43.9 Million
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 305

Recommended

Write a comment